These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38099943)

  • 1. Prophylactic oral application of resveratrol to alleviate acute campylobacteriosis in human gut microbiota associated IL-10-/- mice.
    Heimesaat MM; Schabbel N; Langfeld LQ; Shayya NW; Mousavi S; Bereswill S
    Eur J Microbiol Immunol (Bp); 2023 Dec; 13(4):135-149. PubMed ID: 38099943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic Oral Application of Activated Charcoal Mitigates Acute Campylobacteriosis in Human Gut Microbiota-Associated IL-10
    Heimesaat MM; Schabbel N; Langfeld LQ; Shayya NW; Mousavi S; Bereswill S
    Biomolecules; 2024 Jan; 14(2):. PubMed ID: 38397378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral curcumin ameliorates acute murine campylobacteriosis.
    Heimesaat MM; Mousavi S; Lobo de Sá FD; Peh E; Schulzke JD; Bücker R; Kittler S; Bereswill S
    Front Immunol; 2024; 15():1363457. PubMed ID: 38855111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Oral Application of Carvacrol Alleviates Acute Campylobacteriosis in Mice Harboring a Human Gut Microbiota.
    Foote MS; Du K; Mousavi S; Bereswill S; Heimesaat MM
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carvacrol prophylaxis improves clinical outcome and dampens apoptotic and pro-inflammatory immune responses upon Campylobacter jejuni infection of human microbiota-associated IL-10-/- mice.
    Heimesaat MM; Langfeld LQ; Schabbel N; Mousavi S; Bereswill S
    Eur J Microbiol Immunol (Bp); 2024 May; 14(2):166-179. PubMed ID: 38466378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menthol Pretreatment Alleviates
    Heimesaat MM; Langfeld LQ; Schabbel N; Shayya NW; Mousavi S; Bereswill S
    Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine Fecal Microbiota Transplantation Alleviates Intestinal and Systemic Immune Responses in
    Heimesaat MM; Mrazek K; Bereswill S
    Front Immunol; 2019; 10():2272. PubMed ID: 31616437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol Alleviates Acute
    Heimesaat MM; Mousavi S; Escher U; Lobo de Sá FD; Peh E; Schulzke JD; Kittler S; Bücker R; Bereswill S
    Microorganisms; 2020 Nov; 8(12):. PubMed ID: 33255723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effects of oral benzoic acid application during acute murine campylobacteriosis.
    Du K; Mousavi S; Foote MS; Bereswill S; Heimesaat MM
    Eur J Microbiol Immunol (Bp); 2024 Sep; 14(3):243-260. PubMed ID: 38801662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical Evaluation of Oral Urolithin-A for the Treatment of Acute Campylobacteriosis in
    Mousavi S; Weschka D; Bereswill S; Heimesaat MM
    Pathogens; 2020 Dec; 10(1):. PubMed ID: 33374868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Not only for Christmas: Prophylactic oral application of trans-cinnamaldehyde alleviates acute murine campylobacteriosis.
    Heimesaat MM; Mousavi S; Weschka D; Bereswill S
    Eur J Microbiol Immunol (Bp); 2023 Oct; 13(2):45-56. PubMed ID: 37656630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease alleviating effects following prophylactic lemon and coriander essential oil treatment in mice with acute campylobacteriosis.
    Mousavi S; Weschka D; Bereswill S; Heimesaat MM
    Front Microbiol; 2023; 14():1154407. PubMed ID: 37065112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron Deprivation by Oral Deferoxamine Application Alleviates Acute Campylobacteriosis in a Clinical Murine
    Bereswill S; Mousavi S; Weschka D; Buczkowski A; Schmidt S; Heimesaat MM
    Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease-Alleviating Effects of Peroral Activated Charcoal Treatment in Acute Murine Campylobacteriosis.
    Bereswill S; Mousavi S; Weschka D; Heimesaat MM
    Microorganisms; 2021 Jun; 9(7):. PubMed ID: 34209438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of organic acids benzoate, butyrate, caprylate, and sorbate provides a novel antibiotics-independent treatment option in the combat of acute campylobacteriosis.
    Du K; Foote MS; Mousavi S; Buczkowski A; Schmidt S; Peh E; Kittler S; Bereswill S; Heimesaat MM
    Front Microbiol; 2023; 14():1128500. PubMed ID: 37007531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral application of carvacrol, butyrate, ellagic acid, and 2'-fucosyl-lactose to mice suffering from acute campylobacteriosis - Results from a preclinical placebo-controlled intervention study.
    Mousavi S; Busmann LV; Bandick R; Shayya NW; Bereswill S; Heimesaat MM
    Eur J Microbiol Immunol (Bp); 2023 Nov; 13(3):88-105. PubMed ID: 37987771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune-Modulatory Effects upon Oral Application of Cumin-Essential-Oil to Mice Suffering from Acute Campylobacteriosis.
    Mousavi S; Weschka D; Bereswill S; Heimesaat MM
    Pathogens; 2021 Jun; 10(7):. PubMed ID: 34209990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human microbiota associated IL-10-/- mice: A valuable enterocolitis model to dissect the interactions of Campylobacter jejuni with host immunity and gut microbiota.
    Shayya NW; Foote MS; Langfeld LQ; Du K; Bandick R; Mousavi S; Bereswill S; Heimesaat MM
    Eur J Microbiol Immunol (Bp); 2023 Jan; 12(4):107-122. PubMed ID: 36633627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D in Acute Campylobacteriosis-Results From an Intervention Study Applying a Clinical
    Mousavi S; Lobo de Sá FD; Schulzke JD; Bücker R; Bereswill S; Heimesaat MM
    Front Immunol; 2019; 10():2094. PubMed ID: 31552040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carvacrol ameliorates acute campylobacteriosis in a clinical murine infection model.
    Mousavi S; Schmidt AM; Escher U; Kittler S; Kehrenberg C; Thunhorst E; Bereswill S; Heimesaat MM
    Gut Pathog; 2020; 12():2. PubMed ID: 31921356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.